Fluoreszenzgesteuerte Lymphgefäßversiegelung bei der systematischen Lymphknotendissektion zur Vermeidung von Lymphfisteln und Lymphozelen

 

 Buy Article Permissions and Reprints

Zusammenfassung

Hintergrund Die wichtigsten Morbiditäten der systematischen inguinalen und axillären Lymphknotendissektion sind Lymphfisteln und Serome. Die intraoperative, fluoreszenzgesteuerte Versiegelung der Lymphgefäße könnte die Häufigkeit dieser postoperativen Komplikationen verringern.

Methoden Vor der Lymphadenektomie erfolgte die Intrakutaninjektion von Indocyanin-Farbstoff im Bereich der distalen Extremität. Die Lymphadenektomie wurde nach Standardprotokollen durchgeführt. Während des gesamten Eingriffs wurde Nahinfrarot-Bildgebung eingesetzt, und es wurde eine fluoreszenzgesteuerte Lymphgefäßversiegelung in Echtzeit durchgeführt (Videopräsentation).

Ergebnisse Die fluoreszenzgesteuerte Lymphgefäßversiegelung wurde bei 3 Patienten durchgeführt, die sich einer axillären systematischen Lymphknotendissektion unterzogen. Nach der Injektion des Fluoreszenzfarbstoffs traten keine unerwünschten Ereignisse auf. Alle Patienten konnten ohne Wundkomplikationen entlassen werden.

Schlussfolgerung Die fluoreszenzgesteuerte Lymphgefäßversiegelung könnte eine vielversprechende neue Technik zur Verhinderung von Lymphfisteln nach systematischer Lymphadenektomie sein.

Abstract

Introduction The primary morbidities of inguinal and axillary systematic nodal dissection are lymphatic fistulas and seromas. Intraoperative fluorescence imaging-guided sealing of lymph vessels may prevent these postoperative complications.

Methods Indocyanine dye was injected intracutaneously into the distal limb before the beginning of the lymphadenectomy. Systematic nodal dissection was performed according to standard protocols. Near-infrared imaging was applied throughout the procedure and real-time fluorescence-guided lymph vessel sealing was performed.

Results Fluorescence-guided lymph vessel sealing was implemented in three patients undergoing axillary systematic lymph node dissection. No adverse events occurred following fluorescence dye injection. All patients could be discharged free of wound complications.

Conclusion Fluorescence-guided lymph vessel sealing might be a promising new technique for preventing lymphatic fistulas and lymphocele after systematic lymphadenectomy.

Publication History

Received: 17 December 2021

Accepted after revision: 25 May 2022

Article published online:
03 August 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Coit DG, Thompson JA, Algazi A. et al. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016; 14: 450-473 DOI: 10.6004/jnccn.2016.0051. (PMID: 27059193)
  CrossrefPubMedGoogle Scholar
• 2 Di Monta G, Caraco C, Crispo A. et al. Collagen sealant patch to reduce lymphatic drainage after lymph node dissection. World J Surg Oncol 2012; 10: 275 DOI: 10.1186/1477-7819-10-275. (PMID: 23253298)
  CrossrefPubMedGoogle Scholar
• 3 Glarner CE, Greenblatt DY, Rettammel RJ. et al. Wound complications after inguinal lymph node dissection for melanoma: is ACS NSQIP adequate?. Ann Surg Oncol 2013; 20: 2049-2055 DOI: 10.1245/s10434-012-2856-7. (PMID: 23338482)
  CrossrefPubMedGoogle Scholar
• 4 Mortenson MM, Xing Y, Weaver S. et al. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311). World J Surg Oncol 2008; 6: 63 DOI: 10.1186/1477-7819-6-63. (PMID: 18564433)
  CrossrefPubMedGoogle Scholar
• 5 Matthey-Gie ML, Gie O, Deretti S. et al. Prospective Randomized Study to Compare Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Therapeutic Lymph Node Dissection With or Without the Use of an Ultrasonic Scalpel. Ann Surg Oncol 2016; 23: 1716-1720 DOI: 10.1245/s10434-015-5025-y. (PMID: 26714939)
  CrossrefPubMedGoogle Scholar
• 6 Chang SB, Askew RL, Xing Y. et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol 2010; 17: 2764-2772 DOI: 10.1245/s10434-010-1026-z. (PMID: 20336388)
  CrossrefPubMedGoogle Scholar
• 7 Dardarian TS, Gray HJ, Morgan MA. et al. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol 2006; 101: 140-142 DOI: 10.1016/j.ygyno.2005.10.002. (PMID: 16364412)
  CrossrefPubMedGoogle Scholar
• 8 Judson PL, Jonson AL, Paley PJ. et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol 2004; 95: 226-230 DOI: 10.1016/j.ygyno.2004.07.022. (PMID: 15385136)
  CrossrefPubMedGoogle Scholar
• 9 de Vries M, Vonkeman WG, van Ginkel RJ. et al. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol 2006; 32: 785-789 DOI: 10.1016/j.ejso.2006.05.003. (PMID: 16806794)
  CrossrefPubMedGoogle Scholar
• 10 Benson J. Indocyanine Green Fluorescence for Sentinel Lymph Node Detection in Early Breast Cancer. Ann Surg Oncol 2016; 23: 6-8 DOI: 10.1245/s10434-015-4801-z. (PMID: 26259758)
  CrossrefPubMedGoogle Scholar
• 11 Maddox JS, Sabino JM, Buckingham EB. et al. Utility of indocyanine green fluorescence lymphography in identifying the source of persistent groin lymphorrhea. Plast Reconstr Surg Glob Open 2014; 2: e210 DOI: 10.1097/gox.0000000000000135. (PMID: 25426393)
  CrossrefPubMedGoogle Scholar
• 12 Mihara M, Hara H, Araki J. et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PloS One 2012; 7: e38182 DOI: 10.1371/journal.pone.0038182. (PMID: 22675520)
  CrossrefPubMedGoogle Scholar
• 13 Ogata F, Azuma R, Kikuchi M. et al. Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling. Ann Plast Surg 2007; 58: 652-655 DOI: 10.1097/01.sap.0000250896.42800.a2. (PMID: 17522489)
  CrossrefPubMedGoogle Scholar
• 14 Ballardini B, Santoro L, Sangalli C. et al. The indocyanine green method is equivalent to the (9)(9)mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol 2013; 39: 1332-1336 DOI: 10.1016/j.ejso.2013.10.004. (PMID: 24184123)
  CrossrefPubMedGoogle Scholar
• 15 Neuss H, Raue W, Koplin G. et al. A prospective randomized trial: the influence of intraoperative application of fibrin glue after radical inguinal/iliacal lymph node dissection on postoperative morbidity. Eur J Surg Oncol 2009; 35: 884-889 DOI: 10.1016/j.ejso.2008.09.016. (PMID: 19010636)
  CrossrefPubMedGoogle Scholar
• 16 Pitsinis V, Provenzano E, Kaklamanis L. et al. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer. Surg Oncol 2015; 24: 375-379 DOI: 10.1016/j.suronc.2015.10.002. (PMID: 26555151)
  CrossrefPubMedGoogle Scholar
• 17 Samorani D, Fogacci T, Panzini I. et al. The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective study. Eur J Surg Oncol 2015; 41: 64-70 DOI: 10.1016/j.ejso.2014.10.047. (PMID: 25468752)
  CrossrefPubMedGoogle Scholar
• 18 Alford R, Simpson HM, Duberman J. et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging 2009; 8: 341-354 (PMID: 20003892)
  CrossrefPubMedGoogle Scholar
• 19 Speich R, Saesseli B, Hoffmann U. et al. Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med 1988; 109: 345-346 DOI: 10.7326/0003-4819-109-4-345_2. (PMID: 3395048)
  CrossrefPubMedGoogle Scholar
• 20 Benya R, Quintana J, Brundage B. Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 1989; 17: 231-233 DOI: 10.1002/ccd.1810170410. (PMID: 2670244)
  CrossrefPubMedGoogle Scholar
• 21 Papadia A, Mohr S, Imboden S. et al. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Pregnant Cervical Cancer Patients. J Minim Invasive Gynecol 2016; 23: 270-273 DOI: 10.1016/j.jmig.2015.10.001. (PMID: 26476388)
  CrossrefPubMedGoogle Scholar